Key result
The Colorectal Biochemistry and Haematology Outcome mortality model demonstrated good discrimination and fit for predicting 30-day mortality after colorectal cancer surgery.
Why the study?
Does the Colorectal BHOM accurately predict 30-day mortality and morbidity in patients undergoing colorectal cancer surgery?
Observational (n=704)
No
Does the Colorectal BHOM accurately predict 30-day mortality and morbidity in patients undergoing colorectal cancer surgery?
The Colorectal BHOM provides a simple, minimal-variable model with good discrimination for predicting 30-day mortality after colorectal cancer surgery.
Answers are grounded in this paper and cite their sources.
May aid risk stratification after colorectal cancer surgery; leaves open prospective validation and morbidity prediction.
AIM: To present a new biochemistry and haematology outcome model which uses a minimum dataset to model outcome following colorectal cancer surgery, a concept previously shown to be feasible with arterial operations. METHOD: Predictive binary logistic regression models (a mortality and morbidity model) were developed for 704 patients who underwent colorectal cancer surgery over a 6-year period in one hospital. The variables measured included 30-day mortality and morbidity. Hosmer-Lemeshow goodness of fit statistics and frequency tables compared the predicted vs the reported number of deaths. Discrimination was quantified using the c-index. RESULTS: There were 573 elective and 131 nonelective interventional cases. The overall mean predicted risk of death was 7.79% (50 patients). The actual number of reported deaths was also 50 patients (χ(2) = 1.331, df = 4, P-value = 0.856; no evidence of lack of fit). For the mortality model, the predictive c-index was = 0.810. The morbidity model had less discriminative power but there was no evidence of lack of fit (χ(2) = 4.198, df = 4, P-value = 0.380, c-index = 0.697). CONCLUSIONS: The Colorectal Biochemistry and Haematology Outcome mortality model suggests good discrimination (c-index > 0.8) and uses only a minimal number of variables. However, it needs to be tested on independent datasets in different geographical locations.
No takes yet. Share an insight, caveat, or question.
Farooq et al. (2010) conducted an observational in Colorectal cancer (n=704). Colorectal Biochemistry and Haematology Outcome model (Colorectal BHOM) was evaluated on 30-day mortality (c-index 0.810, p=0.856). The Colorectal Biochemistry and Haematology Outcome mortality model demonstrated good discrimination and fit for predicting 30-day mortality after colorectal cancer surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: